Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Cohort Study in Newly Diagnosed MZL
Sponsor: Fudan University
Summary
Describe the clinical features, diagnosis and treatment status, disease course and primary outcomes of different subtypes of marginal zone B-cell lymphoma (MZL), observe the therapeutic efficacy and safety of different treatment modalities.
Official title: A Prospective, Multi-center, Cohort Study in Newly Diagnosed Marginal Zone B-cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2500
Start Date
2024-05-30
Completion Date
2034-06-30
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Interventions
patients receive optimal treatment or follow-up according to the characteristics of the disease
Patients with MZL who are eligible for enrollment will be evaluated by the investigator and the enrolled patients will receive long-term follow-up after collecting medical history information, biological samples, and oncology data according to the study protocol. This study does not specify a detailed treatment modality, and patients receive optimal treatment or follow-up according to the characteristics of the disease.
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China